Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF)

BACKGROUND: The balance of stroke risk reduction and potential bleeding risk associated with antithrombotic treatment (ATT) remains unclear in atrial fibrillation (AF) at non‐gender CHA(2)DS(2)‐VASc scores 0–1. A net clinical benefit (NCB) analysis of ATT may guide stroke prevention strategies in AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Moonki, Byeon, Kyeongmin, Kang, Ki‐Woon, Lee, Wang‐Soo, Kim, Sang Wook, Park, Yae Min, Hwang, You Mi, Lee, Sung Ho, Jin, Eun‐Sun, Roh, Seung‐Young, Kim, Jin Seok, Ahn, Jinhee, Lee, So‐Ryoung, Choi, Eue‐Keun, Ahn, Min‐Soo, Lee, Eun Mi, Park, Hwan‐Cheol, Lee, Ki Hong, Kim, Min, Choi, Joon Hyouk, Ko, Jum Suk, Kim, Jin Bae, Kim, Changsoo, Lip, Gregory Y. H., Shin, Seung Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264758/
https://www.ncbi.nlm.nih.gov/pubmed/37324774
http://dx.doi.org/10.1002/joa3.12840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264758/
https://www.ncbi.nlm.nih.gov/pubmed/37324774
http://dx.doi.org/10.1002/joa3.12840

Ejemplares similares